New Particle Understandings in Infusion Therapies Relevant to Intensive Care Patients
The objective of the convention was an exchange of information about foreign particles in regards to the production and inspection of pharmaceuticals, as well as the assessment of potential health risks for patients and possible ways of eliminating these. 150 participants from 10 countries discussed the experts' presentations. The following report deals primarily with information from presenters who focused on particle-induced infusion risks for patients.
DOWNLOAD ENGLISH OR GERMAN SUMMARY
Topics:
-
Positive trend – recalls of drugs due to “invisible” particles have decreased in recent years
-
Particle burden for patients – national guidelines change infusion management
-
Nanoparticles in infusions – invisible but not without risks
-
Nanotoxic risk – impairment of microcirculation and increased risk of inflammation
-
Particle risk – clinical and economical consequences
-
Drug incompatibilities – particle generation during the infusion procedure
-
Particle risk – protein-based drugs
-
Particulosis – a new syndrome?
WoCoVA Particle Symposium
Pall Medical Satellite Symposium at WoCoVA 2018 in Copenhagen
GET ACCESS
to the OnDemand session